Rebrain services provide precise brain targeting for DBS neurosurgery, enhancing patient outcomes in Parkinson’s disease and Essential Tremor treatments
24 June 2021

Les Echos Highlights RebrAIn’s AI Innovations in Parkinson’s Disease Treatment

We are thrilled to announce that Les Echos has featured RebrAIn for our innovative application of supervised AI in the treatment of Parkinson’s Disease.

The article explores how our AI-driven solutions are revolutionizing Deep Brain Stimulation (DBS) by enhancing precision and patient outcomes. Co-founded by Professor Emmanuel Cuny and Dr. Nejib Zemzemi, RebrAIn continues to push the boundaries of neurosurgical technology.

Learn more about our groundbreaking work by reading the full article in french on Les Echos.

An English translation by Google is available here.

More news

Ready to learn more how you can challenge the status quo?

Take the next step with us and unlock new opportunities !